A Joint QoL–Survival Framework with Debiased Estimation under Truncation by Death
Torben Martinussen, Klaus Kähler Holst, Christian Bressen Pipper, Per Kragh Andersen · 2026
Read A Joint QoL–Survival Framework with Debiased Estimation under Truncation by Death by Torben Martinussen, Klaus Kähler Holst, Christian Bressen Pipper, Per Kragh Andersen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2602-09537.txt.
Introduction
Quality-of-life results in groups with high death rates face a thorny problem: quality of life is not defined for people who die before a check, so death cuts the result. Torben Martinussen and three co-authors propose a joint quality-of-life and living-on design in their 2026 paper that models both spreads jointly without pushing quality of life beyond death. From multistate models, it extends joint binary-health and death-rate accounts to graded quality-of-life results.
Since treatment effects cannot be fairly squeezed into one number without strong guesses, the approach weighs living on and the joint spread jointly, the latter displayed in a simplex. Guess-light flexible estimators built on efficient influence functions yield steady root-n figures, using machine learning while stating its rules plainly. Test runs and two real-data uses illustrate the method.
Catalog record
| CREATOR | Torben Martinussen, Klaus Kähler Holst, Christian Bressen Pipper, Per Kragh Andersen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2602-09537
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Joint QoL–Survival Framework with Debiased Estimation under Truncation by Death Torben Martinussen, Klaus Kähler Holst, Christian Bressen Pipper, Per Kragh Andersen Abstract Summary Evaluating quality-of-life (QoL) outcomes in populations with high mortality risk is complicated by truncation by death, since QoL is undefined for individuals who do not survive to the planned measurement time. We propose a framework that jointly models the distribution of QoL and survival without extrapolating QoL beyond death. Inspired by multistate formulations, we extend the joint characterization of binary health states and mortality to continuous QoL outcomes. Because treatment effects cannot be meaningfully summarized in a single one-dimensional estimand without strong assumptions, our approach simultaneously considers both survival and the joint distribution of QoL and survival with the latter conveniently displayed in a simplex. We develop assumption-lean, semiparametric estimators based on efficient influence functions, yielding flexible, root-n consistent estimators that accommodate machine-learning methods while making transparent the conditions these must satisfy. The proposed method is illustrated through simulation studies and two real-data applications. Keywords : Debiased learning; Quality of life; Simplex; Truncation by death. 1 Introduction The evaluation of functional outcomes, such as quality of life (QoL), in studies involving patients with high severity of illness or risk of mortality presents significant challenges, as the outcome is only well-defined for subjects who survive until the planned landmark time for measurement. This phenomenon, known as truncation by death , will drive the clinical questions of interest and is therefore a crucial component of both study design and subsequent data analysis. Addressing this complex issue requires careful consideration, as different statistical approaches support fundamentally different clinical research questions and therefore complement each other rather than necessarily agree in terms of conclusions. This premise is especially relevant when treatment affects the terminal event process. When the purpose is to evaluate a treatment effect on an endpoint such as QoL, we argue, similarly to ( 16 ) , that the choice of method should be guided by whether actionable and clinical relevant decisions can be made based on the estimand. Existing methodologies broadly fall into categories that either treat measurements truncated by terminal events as ordinary missing data that can be handled using specific missing at random assumptions, causal methods that aim at estimating the treatment effect in specific subpopulations such as always survivors, and finally methods that model the QoL outcome conditional on not having reached the terminal event. Examples of the first approach include direct modeling of the joint trajectory of both the functional outcome and survival ( 3 ; 26 ; 13 ) . Such approaches, however, effectively extrapolate the QoL endpoint beyond death, which means the interpretation relies heavily on untestable model assumptions which are not desirable in many situations. Moreover, they address the effect of treatment in a hypothetical scenario where it is assumed that death can be prevented. Such a scenario may not be clinically relevant ( 5 ) . Principal stratification methods and in particular Survivor Average Causal Effects (SACE) ( 14 ; 4 ; 23 ; 27 ; 9 ; 18 ) are examples of the second approach. While the principal stratification provides a sound mathematical framework, it has been pointed out that the resulting treatment effect estimates can be difficult to base clinical decisions on, as the patient subgroups might not be identifiable at the time of intervention. More recently, separable effects have been proposed as an alternative ( 17 ; 18 ) , aiming to quantify causal effects of modified versions of the study treatment within an observable subset of the population. These effects, including separable direct and indirect effects, attempt to disentangle causal mechanisms by considering hypothetically modified treatments that operate through distinct causal pathways. While addressing some limitations of SACE, this approach still depends on the conceptualization of imagined interventions (i.e., modified treatments and their isolation conditions) which may be hard to justify in practice. From a clinical transparency perspective, relying on such hypothetical interventions to define a treatment effect can therefore be challenging for practical decision-making, especially in the primary evaluation of treatment efficacy. The last approach, i.e. modeling the QoL outcome conditional on being alive ( 7 ; 8 ) , has been criticized for lack of causal interpretation ( 15 ) as it compares two different populations, survivors in the treated and non-treated group respectively. This means that any treatment effect deduced by contrasting these two populations cannot be viewed in isolation as it may in part be driven by the effect of treatment on survival. In contrast, the approach proposed here provides a framework for jointly describing the distribution of QoL and survival alongside the marginal distribution of survival. This is inspired by existing multistate models that effectively characterize the joint evolution of binary QoL indicators and death. We extend this conceptualization to continuous QoL measurements, recognizing that a disease score is not clinically meaningful beyond the terminal event. The inherent complexity of truncation by death makes it challenging — if not impossible — to summarize treatment effects in a single one-dimensional estimand without unverifiable assumptions, such as those invoked when targeting separable effects. Consequently, we emphasize the importance of jointly considering both the probability of avoiding the terminal event and the joint probability distribution of QoL and being alive. The proposed methodology is assumption-lean and does not require explicit assumptions about the trajectory of QoL or the timing of the terminal event. We further develop debiased estimators based on corresponding efficient influence functions (EIF) ( 1 ; 6 ) . This give rise to efficient and flexible root-n consistent estimators that are asymptotically model-free by enabling data-adaptive methods (e.g. machine learning). We also derive the corresponding remainder term, which clarifies the requirements placed on any machine-learning methods used in practice. The method is investigated in a simulation study using realistic sample sizes and these confirm our theoretical results. We apply the proposed method estimators first to some data concerning quality of life for prostate cancer patients and then also to data from the FLOW clinical kidney outcome trial ( 11 ) , where focus is on the estimated glomerular filtration rate (eGFR). 2 Quantifying treatment effects on survival and QoL jointly 2.1 Preliminaries We use T to denote the time until death and let Y denote the marker, such as quality of life (QoL). The marker is planned to be measured at landmark time point t , but it is unmeasured if T<t (truncation by death). The treatment indicator is denoted by A and baseline covariates by L . We use (T^{a},Y^{a}) to denote potential outcomes if treatment was set to a . Estimands will be formulated for the ”full data” situation (no censoring), but the proposed methods allow for the common observed data situation of right-censoring. Let C denote the right-censoring time and set T^{*}=T\wedge C . Since we are interested in the marker at the landmark point in time t , censoring only affects the needed information if it happens before time t . Thus, we denote an observed data point by O=\{T_{t}^{*}=t\wedge T^{*},\Delta_{t}=I(T\wedge t\leq C),I(t=T_{t}^{*}),YI(t=T_{t}^{*}),A,L\} and assume that \{T,YI(t<T)\} and C are conditionally independent, given A and L . Although our main results apply to a general real-valued marker